Neoplasms, Colorectal Recruiting Phase 1 / 2 Trials for Selumetinib (DB11689)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02450656Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung CancerTreatment